Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VXRT · against 557 other Healthcare companies listed in US-listed
Ranked #345 of 558 · scores higher than 37% of peers
Bars: peers in each 10-point band of the profitability score114 peers with a profitability score of 10–19, including VXRT · Click a bar to see the companies
Mainly because of its return on invested capital, which is weaker than most Healthcare peers.
| Metric | VXRT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 517 reported | -213.4% | -7.0% | 7% | 33% | |
| Operating marginHigher is better · 479 reported | 7.6% | -2.4% | 65% | 33% | |
| Return on assetsHigher is better · 582 reported | 15.0% | -7.8% | 92% | 33% | |
| Return on equityHigher is better · 531 reported | 67.0% | -19.7% | 97% | Context only | |
| Gross marginHigher is better · 601 reported | 24.2% | 43.9% | 40% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 52.9B USD | 99 | 57 | |
| 1 | 578M USD | 99 | 73 | |
| 345 | 1.5B USD | 19 | 32 | |
| 345 | 758M USD | 19 | 35 | |
| 345 | 1.2B USD | 19 | 40 | |
| 345 | 522M USD | 19 | 12 | |
| 345 | 97M USD | 19 | 63 | |
| 354 | 1.0B USD | 18 | 35 | |
| 354 | 118M USD | 18 | 13 | |
| 354 | 3.1B USD | 18 | 39 | |
| 354 | 927M USD | 18 | 41 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score